Dysregulation of the Wnt pathway in adult eosinophilic esophagitis

Diseases of the Esophagus

Volumn 28, Issue 8, 2015, Pages 705-710

  Giannetti, M ^a   Schroeder, H A ^a   Zalewski, A ^a   Gonsalves, N ^a   Bryce, P J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Eosinophilic esophagitis; Remodeling; Signaling

Indexed keywords

AXIN; AXIN 1; BETA CATENIN; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MESSENGER RNA; MYC PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 1; UNCLASSIFIED DRUG; WNT PROTEIN; WNT1 PROTEIN; AXIN1 PROTEIN, HUMAN; CCND1 PROTEIN, HUMAN; FRZB PROTEIN; GENETIC MARKER; GLYCOGEN SYNTHASE KINASE 3; GLYCOPROTEIN; LRP6 PROTEIN, HUMAN; WNT1 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS BIOPSY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BIOPSY; EOSINOPHIL; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; GENETIC MARKER; GENETICS; MALE; ONCOGENE MYC; PATHOLOGY; PROSPECTIVE STUDY; WNT SIGNALING PATHWAY;

ADULT; AXIN PROTEIN; BETA CATENIN; BIOPSY; CYCLIN D1; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILS; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; GENES, MYC; GENETIC MARKERS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; GLYCOPROTEINS; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MALE; PROSPECTIVE STUDIES; RNA, MESSENGER; WNT SIGNALING PATHWAY; WNT1 PROTEIN;

EID: 84954434756     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12273     Document Type: Article

References (30)

1. Liacouras C A, Furuta G T, Hirano I etal. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3-20, e6; quiz 1-2.
2. Hirano I, Moy N, Heckman M G, Thomas C S, Gonsalves N, Achem S R. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut 2013; 62: 489-495.
3. Gonsalves N, Kahrilas P J. Eosinophilic oesophagitis in adults. Neurogastroenterol Motil 2009; 21: 1017-1026.
4. Straumann A, Aceves S S, Blanchard C etal. Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 2012; 67: 477-490.
5. Blanchard C, Mingler M K, Vicario M etal. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 2007; 120: 1292-1300.
6. Blanchard C, Stucke E M, Burwinkel K etal. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol 2010; 184: 4033-4041.
7. Blanchard C, Stucke E M, Rodriguez-Jimenez B etal. A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol 2011; 127: 208-217, 17 e1-7.
8. Hsu Blatman K S, Gonsalves N, Hirano I, Bryce P J. Expression of mast cell-associated genes is upregulated in adult eosinophilic esophagitis and responds to steroid or dietary therapy. J Allergy Clin Immunol 2011; 127: 1307-1308, e3.
9. Matoso A, Mukkada V A, Lu S etal. Expression microarray analysis identifies novel epithelial-derived protein markers in eosinophilic esophagitis. Mod Pathol 2013; 26: 665-676.
10. Gonsalves N, Yang G Y, Doerfler B, Ritz S, Ditto A M, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 2012; 142: 1451-1459, e1; quiz e14-5.
11. de Lau W, Barker N, Clevers H. WNT signaling in the normal intestine and colorectal cancer. Front Biosci 2007; 12: 471-491.
12. Ali I, Rafiee P, Zheng Y etal. Intramucosal distribution of WNT signaling components in human esophagus. J Clin Gastroenterol 2009; 43: 327-337.
13. Clement G, Braunschweig R, Pasquier N, Bosman F T, Benhattar J. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Oncogene 2006; 25: 3084-3092.
14. Zhong X, Desilva T, Lin L etal. Regulation of secreted Frizzled-related protein-1 by heparin. J Biol Chem 2007; 282: 20523-20533.
15. Zou H, Molina J R, Harrington J J etal. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer 2005; 116: 584-591.
16. Brown J, Bothma H, Veale R, Willem P. Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes. World J Gastroenterol 2011; 17: 2909-2923.
17. Blanchard C, Wang N, Stringer K F etal. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006; 116: 536-547.
18. Zhao J, Li L, Wei S etal. Clinicopathological and prognostic role of cyclin D1 in esophageal squamous cell carcinoma: a meta-analysis. Dis Esophagus 2012; 25: 520-526.
19. Vashi R, Hirano I. Diet therapy for eosinophilic esophagitis: when, why and how. Curr Opin Gastroenterol 2013; 29: 407-415.
20. Rothenberg M E. Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009; 137: 1238-1249.
21. Irvine A D, McLean W H, Leung D Y. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365: 1315-1327.
22. Gregorieff A, Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 2005; 19: 877-890.
23. Kuhnert F, Davis C R, Wang H T etal. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc Natl Acad Sci U S A 2004; 101: 266-271.
24. Kagalwalla A F, Akhtar N, Woodruff S A etal. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J Allergy Clin Immunol 2012; 129: 1387-1396, e7.
25. Aceves S S, Chen D, Newbury R O, Dohil R, Bastian J F, Broide D H. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol 2010; 126: 1198-1204, e4.
26. Wong D T, Elovic A, Matossian K etal. Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. Blood 1991; 78: 2702-2707.
27. Lam A P, Gottardi C J. β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol 2011; 23: 562-567.
28. Li C H, Amar S. Inhibition of SFRP1 reduces severity of periodontitis. J Dent Res 2007; 86: 873-877.
29. Lu T X, Sherrill J D, Wen T etal. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J Allergy Clin Immunol 2012; 129: 1064-1759.
30. Fu J, Tang W, Du P etal. Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis. BMC Syst Biol 2012; 6: 68.